期刊文献+

低剂量rhG-CSF对56例非血缘供者外周造血干细胞动员 被引量:12

Peripheral Blood Stem Cell Mobilization with Low Dose rhG-CSF in 56 Unrelated Healthy Donors
下载PDF
导出
摘要 本研究观察低剂量人重组粒细胞集落刺激因子(rhG-CSF)对非血缘健康供者的影响,探讨用于中华造血干细胞捐赠者资料库提供的非血缘健康供者外周造血干细胞动员方案。56例非血缘健康供者接受rhG-CSF 5μg/(kg.d)皮下注射,在动员第4、5两天或第5、6两天采集干细胞,观察动员效果及不良反应,检测动员前后血常规指标、CD3+、CD4+、CD8+和CD20+细胞比例;对采集物进行单个核细胞(MNC)和CD34+细胞计数;对所有供者随访至2006年5月31日。结果显示:在rhG-CSF动员过程中出现1级毒副作用(按WHO分级标准):腰背酸痛17.9%(10/56)、焦虑失眠8.9%(5/56)、疲乏4.5%(3/56)等,无需特殊处理,无需终止动员。第4、5两天采集和第5、6两天采集所得的MNC分别是(5.95±1.52)×108/kg和(7.19±2.12)×108/kg;CD34+细胞分别是(3.03±1.09)×106/kg和(7.92±2.50)×106/kg。血红蛋白水平、血小板量、CD3、CD4、CD8、CD20百分比动员前后无变化。结论:5μg/(kg.d)rhG-CSF用于非血缘健康供者的动员是安全而有效的。 The study was aimed to observe the effect of recombinant human granulocyte-colony stimulating factors (rhG-CSF) in low dose on peripheral blood stem cell (PBSC) mobilization in unrelated healthy normal donors. G-CSF was administered at 5 μg/(kg· d) subcutaneously for successive 5 or 6 days to 56 unrelated donors. Stem cells were harvested on the fourth and fifth days or on the fifth and sixth days. The numbers of mononuclear cells ( MNC), CD34^+ cells and Hb, Pit, and CD3^+ , CD4^+ , CD8^+ and CD20^+cells were determined during the mobilization. The results showed that most common adverse events were bone pain (17.9%, 10/56), agrypnia (8.9% ,5/56) and lassitude (4. 5% ,3/56) during rhG-CSF mobilization, but all donors were suffered less than grade Ⅱ according to the WHO criteria, and did not need to stop the mobilization and not neeed to give special treatment. In harvest on day 4 -5 and 5 - 6, MNC count was (5.95 ±1.52) × 10^8/kg and (7.19 ±2.12) x 10^8/kg; CD34^+ cells count was (3.03 ± 1.09) × 10^6/kg and (7.92 ± 2.50) × 10^6/kg. There were no significant differences in hemoglobin level and platelet count, the percentage of CD3^+ cells, CD4^+ cells, CD8^+ cells and CD20^+ cells between pre-mobilization and post-mobilization of rhG-CSF. It is conc/uded that the low dose of rhG-CSF 5μg/( kg·d) for peripheral blood stem cell mobilization in unrelated healthy normal donors is safe and effective.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第2期348-351,共4页 Journal of Experimental Hematology
关键词 粒细胞集落刺激因子 外周血造血干细胞动员 非血缘供耆 granulocyte-colony stimulating factor peripheral blood hematopoietic stem cell mobilization unrelated donor
  • 相关文献

参考文献9

  • 1Bakken R,van-Walreaven AM,Egeland T,et al.Donor commitment and patient needs.Bone Marrow Transplant,2004;33:225 -230
  • 2Suzuya H,Watanabe T,Nakagawa R,et al.Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.Vox Sang,2005; 89:229 -235
  • 3Anderlini P,Donato M,Chan KW,et al.Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:the M.D.Anderson Cancer Center experience.Transfution,1999;39:555-560
  • 4Bensinger W,Buckner CD,Rowley S,et al.Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.Bone Marrow Transplant,1996;17(Suppl 2):S19 -S21
  • 5Grigg AP.Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia.Blood,2001 ;97:3998-399
  • 6Stroncek D,Shawker T,Follmann D,et al.G-CSF induced spleen size changes in peripheral blood progenitor cell donors.Transfusion,2003 ;43:609 -613
  • 7Bonsignore MR,Morici G,Santoro A,et al.Circulating hematopoietic progenitor cells in runners.J Appl Physiol,2002;93:1691 -1697
  • 8Croop JM,Cooper R,Seshadri R,et al.Large-seale mobilization and isolation of CD34+ cells from normal donor.Bone Marrow Transplant,2000; 26:1271-1279
  • 9陈彤,谢毅.VLA-4整联蛋白和造血细胞迁移之间的相关关系研究(英文)[J].中国实验血液学杂志,2003,11(3):230-234. 被引量:1

二级参考文献12

  • 1Kessinger A, Armitage JO, Landmark JD, et al. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol, 1986; 14:192- 196.
  • 2Prosper F, Stroncek D, Verfaillie CM, Phenotypic and functional characterization of long-term culture initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood, 1996; 88:2033-2042.
  • 3To LB, Haylock DN, Simmons PJ, et al. The biology and clinical uses of blood stem cells. Blood, 1997; 89:2233-2258.
  • 4Link DC. Mechanisms of granulocyte colony-stimulating factor-induced hematopoietic progenltor-cell mobilization. Semin Hematol,2000; 37(Suppl 2) : 25 - 32.
  • 5Zeng D, Dejbakhsh-Jones S, Strober S. Grandocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood, 1997; 90:453 - 463.
  • 6Papayannopoulou T. Mechanisms of stem-/progenitor-cell mobilization: The anti-VLA-4 paradigm. Semin Hematol, 2000;37(Suppl 2) : 11 - 18.
  • 7Roberts AW, Metcalf D. Granuloeyte colony-stimulatlng factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol, 1994; 22:1156- 1163.
  • 8Okada S, Nakauchi H, Nagayoshi K, et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood, 1992; 80:3044 - 3050.
  • 9Korbling M, Champlin R. Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts. Stem Cells, 1996; 14:185- 195.
  • 10Prosper F, Stroncek D, McCarthy JB, et al. Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4β1 integrin expression and function. J Clin Invest, 1998; 101:2456- 2467.

同被引文献138

引证文献12

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部